Eistland -
eistneska -
Ravimiamet
cyklokapron õhukese polümeerikattega tablett
meda ab - traneksaamhape - õhukese polümeerikattega tablett - 500mg 50tk; 500mg 100tk
Eistland -
eistneska -
Ravimiamet
xymelin ninasprei, lahus
takeda pharma as - ksülometasoliin - ninasprei, lahus - 0,5mg 1ml 15ml 1tk
Eistland -
eistneska -
Ravimiamet
muse 250mcg uretraalpulk
meda ab - alprostadiil - uretraalpulk - 250mcg 1tk; 250mcg 6tk
Eistland -
eistneska -
Ravimiamet
relifex õhukese polümeerikattega tablett
meda ab - nabumetoon - õhukese polümeerikattega tablett - 1g 20tk; 1g 100tk
Eistland -
eistneska -
Ravimiamet
relifex dispergeeruv tablett
meda ab - nabumetoon - dispergeeruv tablett - 1g 100tk; 1g 20tk
Eistland -
eistneska -
Ravimiamet
xymelin ninatilgad, lahus
takeda pharma as - ksülometasoliin - ninatilgad, lahus - 0,5mg 1ml 10ml 1tk
Eistland -
eistneska -
Ravimiamet
xefo rapid õhukese polümeerikattega tablett
takeda pharma as - lornoksikaam - õhukese polümeerikattega tablett - 8mg 6tk; 8mg 20tk; 8mg 100tk; 8mg 50tk; 8mg 30tk
Eistland -
eistneska -
Ravimiamet
xefo süstelahuse pulber ja lahusti
takeda pharma as - lornoksikaam - süstelahuse pulber ja lahusti - 8mg 5tk; 8mg 10tk; 8mg 1tk
Evrópusambandið -
eistneska -
EMA (European Medicines Agency)
bimervax
hipra human health s.l. - sars-cov-2 virus recombinant spike (s) protein receptor binding domain (rbd) fusion heterodimer – b.1.351-b.1.1.7 strains - covid-19 virus infection - vaktsiinid - bimervax is indicated as a booster for active immunisation to prevent covid-19 in individuals 16 years of age and older who have previously received a mrna covid-19 vaccine.
Eistland -
eistneska -
Ravimiamet
hipracal-fm infusioonilahus
laboratorios hipra s.a. - kaltsiumglükonaat+magneesiumkloriid - infusioonilahus - 175mg+21,9mg 1ml 500ml 12tk; 175mg+21,9mg 1ml 500ml 1tk